{"name":"Notable Labs","slug":"notable","ticker":"NTBL","exchange":"NASDAQ","domain":"notablelabs.com","description":"Notable Labs is a biotech company focused on precision medicine and diagnostics. Their key products include [list of major drugs]. As a leader in the biotech sector, Notable Labs is well-positioned to capitalize on the growing demand for targeted therapies and diagnostic solutions.","hq":"Foster City, CA","founded":0,"employees":"","ceo":"Thomas Graney","sector":"Biotech / Precision Medicine / Diagnostics","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$25M","metrics":{"revenue":310000,"revenueGrowth":-52.9,"grossMargin":0,"rdSpend":4706000,"netIncome":-11264000,"cash":19541000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2023"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Notable Labs' Lead Product patent cliff ($X.XB at risk)","drug":"Notable Labs' Lead Product","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"Notable Labs Reports Q4 2023 Earnings","summary":"Notable Labs reported Q4 2023 earnings, with revenue of $X.XB and a net loss of $Y.YB.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"Notable Labs Partners with [Partner Name] for [Partnership Details]","summary":"Notable Labs has partnered with [Partner Name] to develop [Partnership Details].","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBVVjNEUEhJLThJTEI1X29NODM2alBha3BDdUREUDBiOE01ZkJoREw5enFmRkVTRmdDbTBlajlNeXBSdUhwRjFYR2hMZUVsQjFCWXRv?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"NTBL Stock Price, News & Analysis - Stock Titan","headline":"NTBL Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBkYWotSkNYVzh4QnBLYVdkNG5vYzVGYWVnQ1dhbDNzWGxod21WRHp5SDhvWHR3NGFCTjd3VkFuSjVHdi1kYTFyOWEyV21lZkM4bHFR?oc=5","date":"2024-11-26","type":"pipeline","source":"Yahoo Finance UK","summary":"Notable Labs, Ltd. (NTBLQ) stock price, news, quote and history - Yahoo Finance UK","headline":"Notable Labs, Ltd. (NTBLQ) stock price, news, quote and history","sentiment":"neutral"},{"date":"2024-10-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQeENkMml5TEl5MXJoaDAwbzczblVmMmEyTFd2dThhbVg5ekZ6SlViZzhKX0pqN0d3SW1IZ25IMTA5eXdvU0NwNVE5ZE0wS2NXNHo0QkNsVU9nNzgxR19YeEhUQmQzYV81REE3RTlMalV6QzdHVTBRN1FGdGswdEdRdEpzUkFKVlVSR2VRRmRXRE0tRTA1UzA5aGpNQ284bnRDeTM2QUJFUQ?oc=5","date":"2024-10-15","type":"pipeline","source":"Investing.com","summary":"Notable Labs files for bankruptcy, board resigns - Investing.com","headline":"Notable Labs files for bankruptcy, board resigns","sentiment":"neutral"},{"date":"2024-10-15","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-09-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-09-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-08-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-08-14","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2024-08-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-07-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-07-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-05-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2024-05-15","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE8wN2pjQmhqSnF1QU84N05sNGNWb0JkVVhWVHdIYnhUdGhBcDZGZ1laNTM3X3B5REhnVDl6am1wN1BySUVwUjU5Qm5tdHAzRWlLaV9kSjk0TWpPdw?oc=5","date":"2023-10-18","type":"pipeline","source":"MarketBeat","summary":"Notable Labs (NTBL) Stock Price, News & Analysis $NTBL - MarketBeat","headline":"Notable Labs (NTBL) Stock Price, News & Analysis $NTBL","sentiment":"neutral"}],"patents":[{"drugName":"Notable Labs' Lead Product","drugSlug":"generic-name","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US"}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Company1","Company2","Company3"],"therapeuticFocus":["Precision Medicine","Diagnostics"],"financials":{"source":"sec_edgar","revenue":310000,"revenuePeriod":"2023-12-31","revenueHistory":[{"value":310000,"period":"2023-12-31"},{"value":658000,"period":"2022-12-31"},{"value":8000,"period":"2022-12-31"},{"value":768000,"period":"2021-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":4706000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-11264000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":19541000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}